New regulations threaten heavy costs for Canada's industry
This article was originally published in Clinica
Executive Summary
Canada's new device regulations and the associated cost recovery scheme will create substantial increases in costs for medical device manufacturers, say two new independent reports prepared for the Therapeutic Products Programme. Both the regulations and cost recovery are due to come into force on July 1 (see Clinica No 788/89, p 5).